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philosophies to discern how the beliefin this
effect was achieved. To tell more, however,
would be to spoil a good story. The chapters on
the other machines are equally well done if
having slightly less ofthe flavour ofthe
detective story. In two chapters the authors
desert their genre and pursue the precursors of
modern devices: graphs and photographic
depictions. Both ofthese chapters are
informative and theoretically interesting,
especially the latter, which includes a useful
discussion ofhow photographic (and other)
images in the past were regarded as either
natural (realist) or conventional
representations. According to which approach
was adopted unusual images could be
designated as either unnatural distortions of
nature or extensions ofvision. Such a decision
has had important consequences in the history
of science as in the debate over Galileo's
telescope. Let this volume be a lesson to
historians ofmedicine and let us see contextual
studies notjust ofodd ideas but ofodd
machines: Perkin's tractors or the
Pulvermacher Belt, for instance.
Christopher Lawrence, Wellcome Institute
Lance Day and Ian McNeil (eds),
Biographical dictionary ofthe history of
technology, London and New York, Routledge,
1996, pp. xiii, 844, £85.00 (0-415-06042-7).
This dictionary includes nearly 1,300 entries
covering those who have contributed to "the
advance oftechnology" from antiquity. They
are, the editors state, largely male white
Europeans and North Americans, but Day and
McNeil have, it seems, done their best to assess
the contribution ofwomen and non-white
people. Thejustification, and the unitary theme
for the volume, is that contributors to
technological innovation are what count. This is
not a dictionary oftechnologists, but of
inventors. However, the editors are not
consistent: my eye fell on the entry for Sir
James Lithgow, an important British shipbuilder
who, on the evidence ofthe entry, was not
responsible for a single innovation. The entries
are short:just over half a page on average.
There are more entries for aerospace than for
agriculture and food; more on railways than on
weapons. But medicine is well represented with
eighty-four entries. One wonders what
judgements were made about what is important.
The quality of the volume is, to be frank,
low. One very noticeable feature is how out-of-
date the suggestions for further reading are.
The most recent bibliographic reference for
Joseph Lister dates from 1948; Howard
Florey's entry has no secondary literature. The
entry on Henry Ford does not include any
reference to the literature produced by
professional historians oftechnology. This is
by no means unusual: the contributors to the
volume seem unaware of most ofthe
professional history oftechnology over the last
twenty or so years. The entry on Edison, for
example, has no reference to the work ofT P
Hughes. The entry on Sir Alaistair Pilkington
does not refer to the well-known history of the
Pilkington firm. And so on. It is thus not
surprising to find very few professional
historians oftechnology among the
contributors. The book is thus neither a guide
to recent knowledge, nor does it give any
access to it. Its only use for the historian of
technology is as a quick reference guide, and
as a poignant reminder ofwhat the history of
technology used to be like.
D Edgerton, Imperial College, London
J Rosser Matthews, Quantification and the
questfor medical certainty, Princeton
University Press, 1995, pp. x, 195, £32.00,
$39.50 (0-691-03794-9).
The launch ofthejournal Statistics in
Medicine in 1982 marked, by one set of
criteria, an important step in the emergence of
medical statistics as an established medical
specialty. In the folk memory ofthat young
discipline, its modern origins are very precisely
dated to 1937, the year in which Austin
Bradford Hill published in the Lancet the
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lectures which later became his Principles of
medical statistics. It is widely recognized that
in the forty-five years between textbook and
journal, statistics became both a universal tool
ofmedical research and a final court ofappeal
for new procedures and therapies. It should not
be surprising, therefore, that the relationship
between statistics and medicine has become a
focus of interest for historians oftwentieth-
century medicine in recent years, and that a
flourishing school ofstudents ofthe clinical
trial is now at work. At its broadest, this
interest in quantification spills over into
consideration of the cultural meanings of
objectivity in western societies, as in Theodore
Porter's Trust in numbers (1995); in the
narrower medical context, Rosser Matthews'
Quest seeks to give the clinical trial a "proper"
contextual history, by tracing debates about the
use ofcomparative statistics in therapeutics
back into the nineteenth century.
Matthews has selected three "crucial"
debates for study: that surrounding the
numerical method ofPierre Louis in early
nineteenth-century France; that provoked by
Louis among German physiologists in the
1850s; and that between bacteriologists and
biometricians over the opsonic index in early
twentieth-century Britain. A central theme of
this last case-study, which Matthews rightly
highlights, is the part played by Major
Greenwood, later Professor ofEpidemiology
and Vital Statistics at the London School of
Hygiene and Tropical Medicine, in softening
up the receptivity ofhis medical colleagues to
statistical methods-a preparation which was
essential to the eventual impact ofBradford
Hill's more concerted attempt to reconcile the
profession to the use of statistics. The unifying
theme ofMatthews' work is, indeed, the
profound antipathy which medical men of all
kinds nourished towards the adoption of
statistical methods. It was an antipathy which
Bradford Hill later emphasized in his
unpublished 'Memoirs': he did not discuss
randomization in the first edition ofthe
Principles because "you have to teach the
clinicians to walk before they can run".
Drawing on the work ofChristopher Lawrence,
Matthews attributes medical reluctance to deal
in statistics to the dominance of
"incommunicable knowledge", the traditional
blind ofthe doctors' art, his expertjudgement.
In Matthews' view, it took the highly
publicized crisis over thalidomide in the early
1960s to force acceptance ofquantitative
methods on the profession: thalidomide for the
first time made a public issue of the doctor's
professional judgement. It is a conclusion that
fits well with Theodore Porter's general
argument that quantification "becomes most
important where elites are weak, where private
negotiation is suspect, and where trust is in
short supply", but one that does not really
acknowledge the fundamental reluctance ofthe
non-mathematically minded to become
entangled with numbers. This is a thoughtful,
clearly-expressed, and carefully contextualized
contribution to the history of the clinical trial;
there is, however, also the most delicate whiff
ofWhiggery in Matthews' several references
to "the triumph ofthe clinical trial", and the
final section drawing comparisons between
past and present debates might well have noted
in passing modern critiques ofthe clinical
trial-expensive, cumbersome, time-
consuming and not, in the final event, always a
trustworthy indicator ofthe practical value and
long-term therapeutic implications ofthe
treatments assessed.
Anne Hardy, Wellcome Institute
Kurt Goldstein, The organism: a holistic
approach to biology derivedfrompathological
data in man, New York, Zone Books, 1995,
pp. 422, £22.95 (0-942299-96-5). Distributed
by The MIT Press.
This is a quality reprint ofthe 1963
American edition; the book was originally
published in German in 1934. The neurologist
Kurt Goldstein established his reputation with
detailed studies ofthe symptoms and recovery
ofbrain-damaged patients during World War I.
In the 1920s, he was known as a leading critic
ofparticulate theories ofthe localization of
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